3D MR-spectroscopic imaging assessment of metabolic activity in the prostate during the PSA "bounce" following 125iodine brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 2, 2011, Pages 371-378

  Kirilova, Anna ^a   Damyanovich, Andrei ^b   Crook, Juanita ^a   Jezioranski, John ^b   Wallace, Kris ^a   Pintilie, Melania ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Brachytherapy; MR Spectroscopy; Prostate cancer; PSA bounce

Indexed keywords

BRACHYTHERAPY; COMPLEX RELATIONSHIPS; LOCAL RECURRENCE; MAGNETIC RESONANCE SPECTROSCOPIC IMAGING; METABOLIC ACTIVITY; METABOLIC CHANGES; MR SPECTROSCOPY; POSITIVE SITES; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE CANCERS; PROSTATE SPECIFIC ANTIGEN; PSA BOUNCE; SIGNAL INTENSITIES; SPECTROSCOPIC IMAGING;

BIOPSY; DISEASES; IODINE; MAGNETIC RESONANCE; MAGNETIC RESONANCE SPECTROSCOPY; METABOLISM; ONCOLOGY; RADIOTHERAPY; TISSUE;

THREE DIMENSIONAL;

CHOLINE; CREATINE; IODINE 125; PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; BIOLOGICAL MONITORING; BRACHYTHERAPY; CANCER RECURRENCE; CANCER RISK; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; THREE DIMENSIONAL ECHOCARDIOGRAPHY;

BRACHYTHERAPY; CHOLINE; CITRIC ACID; CREATINE; HUMANS; IODINE RADIOISOTOPES; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 78650801804     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.10.066     Document Type: Article

References (34)

1. P.D. Grimm, J.C. Blasko, and J.E. Sylvester 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy Int J Radiat Oncol Biol Phys 51 2001 31 40
2. J. Crook, S. Malone, and G. Perry Postradiotherapy prostate biopsies: What do they really mean? Results for 498 patients Int J Radiat Oncol Biol Phys 48 2000 355 367
3. 3) spatial resolution Radiology 198 1996 795 805
4. D. Taussky, L. Austen, and A. Toi Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion Int J Radiat Oncol Biol Phys 62 2005 974 980
5. T.K. Tran, D.B. Vigneron, and N. Sailasuta Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer Magn Reson Med 43 2000 23 33
6. American Society for Therapeutic Radiology and Oncology Consensus Panel Consensus statement: Guidelines for PSA following radiation therapy Int J Radiat Oncol Biol Phys 37 1997 1035 1041
7. M. Roach 3rd, G. Hanks, and H. Thames Jr. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 65 2006 965 974
8. J. Crook, C. Gillan, and I. Yeung PSA kinetics and PSA bounce following permanent seed prostate brachytherapy Int J Radiat Oncol Biol Phys 69 2007 426 433
9. F.A. Critz, W.H. Williams, and J.B. Benton Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer J Urol 163 2000 1085 1089
10. R.G. Stock, N.N. Stone, and J.A. Cesaretti Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: descriptions and implications Int J Radiat Oncol Biol Phys 56 2003 448 453
11. C.M. Iannuzzi, R.G. Stock, and N.N. Stone PSA kinetics following I-125 radioactive seed implantation in the treatment of T1-T2 prostate cancer Radiat Oncol Investig 7 1999 30 35
12. C. Patel, M.A. Elshaikh, and K. Angermeier PSA bounce predicts early success in patients with permanent iodine-125 prostate implant Urology 63 2004 110 113
13. W. Cavanagh, J.C. Blasko, and P.D. Grimm Transient elevation of serum prostate-specific antigen following (125)I/(103)Pd brachytherapy for localized prostate cancer Semin Urol Oncol 18 2000 160 165
14. J.P. Ciezki, C.A. Reddy, and J. Garcia PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time Int J Radiat Oncol Biol Phys 64 2006 512 517
15. F.A. Critz, W.H. Williams, and A.K. Levinson Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: The relationship to patient age J Urol 170 2003 1864 1867
16. G.S. Merrick, W.M. Butler, and K.E. Wallner Prostate-specific antigen spikes after permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 54 2002 450 456
17. G.S. Merrick, W.M. Butler, and K.E. Wallner Prostate-specific antigen (PSA) velocity and benign prostate hypertrophy predict for PSA spikes following prostate brachytherapy Brachytherapy 2 2003 181 188
18. D. Reed, K. Wallner, and G. Merrick Clinical correlates to PSA spikes and positive repeat biopsies after prostate brachytherapy Urology 62 2003 683 688
19. A. Toledano, L. Chauveinc, and T. Flam PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: A study of 295 patients with a minimum 3-year followup Brachytherapy 5 2006 122 126
20. Gomez-Iturriaga Pina A, Crook J, Borg J, et al. 125Iodine brachytherapy as monotherapy in men aged <55 years with favorable prostate cancer. Urology. In press.
21. D.M. Mitchell, R. Swindell, and T. Elliott Analysis of prostate-specific antigen bounce after I(125) permanent seed implant for localised prostate cancer Radiother Oncol 88 2008 102 107
22. M.R. Engelbrecht, G.J. Jager, and R.J. Laheij Local staging of prostate cancer using magnetic resonance imaging: A meta-analysis Eur Radiol 12 2002 2294 2302
23. S.S. Sonnad, C.P. Langlotz, and J.S. Schwartz Accuracy of MR imaging for staging prostate cancer: A meta-analysis to examine the effect of technologic change Acad Radiol 8 2001 149 157
24. J.C. Weinreb, J.D. Blume, and F.V. Coakley Prostate cancer: Sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy - results of ACRIN prospective multi-institutional clinicopathologic study Radiology 251 2009 122 133
25. F.V. Coakley, J. Kurhanewicz, and Y. Lu Prostate cancer tumor volume: Measurement with endorectal MR and MR spectroscopic imaging Radiology 223 2002 91 97 (Pubitemid 34258194)
26. D. Beyersdorff, M. Taupitz, and B. Winkelmann Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: Value of MR imaging Radiology 224 2002 701 706
27. J. Crook MR spectroscopy in the staging and followup of Iodine 125 prostate brachytherapy [Abstract] Radiother Oncol 69 Suppl. 1 2003 S13
28. J. Kurhanewicz, D.B. Vigneron, and H. Hricak Prostate cancer: Metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging Radiology 200 1996 489 496
29. C. Menard, I.C. Smith, and R.L. Somorjai Magnetic resonance spectroscopy of the malignant prostate gland after radiotherapy: A histopathologic study of diagnostic validity Int J Radiat Oncol Biol Phys 50 2001 317 323
30. U.G. Mueller-Lisse, M.G. Swanson, and D.B. Vigneron Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging Magn Reson Med 46 2001 49 57
31. B. Pickett, R.K. Ten Haken, and J. Kurhanewicz Time to metabolic atrophy after permanent prostate seed implantation based on magnetic resonance spectroscopic imaging Int J Radiat Oncol Biol Phys 59 2004 665 673
32. F.V. Coakley, H. Hricak, and A.E. Wefer Brachytherapy for prostate cancer: Endorectal MR imaging of local treatment-related changes Radiology 219 2001 817 821 (Pubitemid 32476279)
33. F.V. Coakley, H.S. Teh, and A. Qayyum Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: Preliminary experience Radiology 233 2004 441 448
34. J. Crook, I. Yeung, and J. Borg Iodine 125 Prostate brachytherapy 9-year experience with over 1000 patients [Abstract] Urology 72 2008 S40